shutterstock_1383422144-janson-george
Janson George / Shutterstock.com
2 July 2019Americas

Illumina accuses BGI of patent infringement, again

Genetic sequencing company Illumina has continued its campaign of filing patent lawsuits against rival BGI, with the filing of three additional infringement suits.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
21 February 2020   Genetic sequencing company Illumina is seeking a preliminary injunction to stop its China-based rival BGI from distributing DNA sequencers in the US.
Americas
18 June 2020   Genetic sequencing company Illumina has obtained a preliminary injunction against its China-based rival BGI.
Big Pharma
25 February 2021   Chinese genome sequencing company BGI has been given the go-ahead to appeal an English High Court ruling in an ongoing lawsuit launched by competitor Illumina regarding its DNA sequencing patents.

More on this story

Americas
21 February 2020   Genetic sequencing company Illumina is seeking a preliminary injunction to stop its China-based rival BGI from distributing DNA sequencers in the US.
Americas
18 June 2020   Genetic sequencing company Illumina has obtained a preliminary injunction against its China-based rival BGI.
Big Pharma
25 February 2021   Chinese genome sequencing company BGI has been given the go-ahead to appeal an English High Court ruling in an ongoing lawsuit launched by competitor Illumina regarding its DNA sequencing patents.

More on this story

Americas
21 February 2020   Genetic sequencing company Illumina is seeking a preliminary injunction to stop its China-based rival BGI from distributing DNA sequencers in the US.
Americas
18 June 2020   Genetic sequencing company Illumina has obtained a preliminary injunction against its China-based rival BGI.
Big Pharma
25 February 2021   Chinese genome sequencing company BGI has been given the go-ahead to appeal an English High Court ruling in an ongoing lawsuit launched by competitor Illumina regarding its DNA sequencing patents.